BZP-party pills: A review of research on benzylpiperazine as a recreational drug

International Journal of Drug Policy

Volumn 22, Issue 2, 2011, Pages 95-101

  Cohen, Bruce M Z ^a   Butler, Rachael ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

BZP; Designer drugs; Herbals; Legal highs; Party pills

Indexed keywords

1 (3 TRIFLUOROMETHYLPHENYL)PIPERAZINE; ALCOHOL; AMPHETAMINE; BENZYLPIPERAZINE; DEXAMPHETAMINE; ILLICIT DRUG; METHAMPHETAMINE; RECREATIONAL DRUG; UNCLASSIFIED DRUG;

DRUG LEGISLATION; GOVERNMENT REGULATION; HEALTH HAZARD; HUMAN; MARKETING; NEW ZEALAND; PREVALENCE; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; SHORT SURVEY; SOCIAL PROBLEM; SUBSTANCE ABUSE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; COMMERCE; CRIME; DESIGNER DRUGS; DRUG AND NARCOTIC CONTROL; FEMALE; HARM REDUCTION; HUMANS; MALE; PIPERAZINES; RISK ASSESSMENT; STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TABLETS; YOUNG ADULT;

EID: 79953060384     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugpo.2010.12.002     Document Type: Short Survey

References (44)

1. Advisory Council on the Misuse of Drugs Control of 1-benzylpiperazine (BZP) and related compounds 2008, Advisory Council on the Misuse of Drugs, London.
2. Allen And Clarke Policy And Regulatory Specialists Limited Analysis of submissions. Proposal to classify BZP and related substances as Class C controlled drugs under the Misuse of Drugs Act 1975. Final report 2007, Allen and Clarke Policy and Regulatory Specialists Limited, Wellington.
3. Antia U. 'Party pill' drugs - BZP and TFMPP. New Zealand Medical Journal 2009, 122(1307):55-68.
4. Antia U., Lee H.S., Kydd R.R., Tingle M.D., Russell B.R. Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants. Forensic Science International 2009, 186:63-67.
5. Antia U., Tingle M.D., Russell B.R. In vivo interactions between BZP and TFMPP (party pill drugs). New Zealand Medical Journal 2009, 122(1303):29-38.
6. Balmelli C., Kupferschmidt H., Rentsch K., Schneemann M. Fatal brain edema after ingestion of ecstasy and benzylpiperazine. Deutsche Medizinische Wochenschrift 2001, 126:809-811.
7. Bellamy P. Legal party pills in New Zealand 2007, Wellington Parliamentary Library, Wellington.
8. Butler R., Sheridan J. Highs and lows: Patterns of use, positive and negative effects of benzylpiperazine-containing party pills (BZP-party pills) amongst young people in New Zealand. Harm Reduction Journal 2007, 4(18). http://www.harmreductionjournal.com/content/4/1/18.
9. Bye C., Munro-Faure A.D., Peck A.W., Young P.A. A comparison of the effects of 1-benzylpiperazine and dexamphetamine on human performance tests. European Journal of Clinical Pharmacology 1973, 6(3):163-169.
10. Campbell H., Cline W., Evans M., Lloyd J., Peck A.W. Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts. European Journal of Clinical Pharmacology 1973, 6(3):170-176.
11. Dawkins K. The great BZP hoax. New Zealand Law Journal 2008, 6:250-253.
12. Degenhardt L., Dierker L., Chiu W.T., Medina-Mora M.E., Neumark Y., Sampson N., et al. Evaluating the drug use " gateway" theory using cross-national data: Consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug and Alcohol Dependence 2010, 108(1-2):84-97.
13. Elliott S., Smith C. Investigation of the first deaths in the United Kingdom involving the detection and quantitation of the Piperazines BZP and 3-TFMPP. Journal of Analytical Toxicology 2008, 32(2):172-177.
14. European Monitoring Centre for Drugs and Drug Addiction. (2007). Risk assessment report of a new psychoactive substance: 1-Benzylpiperazine (BZP) (in accordance with Article 6 of council decision 2005/387/JHA on information exchange, risk assessment and control of new psychoactive substances). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
15. European Monitoring Centre for Drugs and Drug Addiction. (2008). Council decision: 'Appropriate controls' for BZP-new drug BZP to be placed under control across the EU. News Release No. 2/2008. Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
16. European Monitoring Centre for Drugs and Drug Addiction. (2009). Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances. Luxembourg: Office for Official Publications of the European Communities.
17. Expert Advisory Committee on Drugs. (2004). The Expert Advisory Committee on Drugs (EACD). Advice to the Minister on: Benzylpiperazine (BZP). Wellington: Expert Advisory Committee on Drugs.
18. Expert Advisory Committee on Drugs. (2006a). Further EACD advice on benzylpiperazine (BZP) and related substances. Wellington: Expert Advisory Committee on Drugs.
19. Expert Advisory Committee on Drugs. (2006b). Minutes. Expert Advisory Committee on Drugs meeting, 29 November 2006. Wellington: National Drug Policy Team.
20. Expert Advisory Committee on Drugs. (2007). Further EACD advice on benzylpiperazine (BZP) and related substances. Wellington: Expert Advisory Committee on Drugs.
21. Gee P., Fountain J. Party on? BZP party pills in New Zealand. New Zealand Medical Journal 2007, 120(1249). http://www.nzma.org.nz/journal/120-1249/2422.
22. Gee P., Gilbert M., Richardson S., Moore G., Paterson S., Graham P. Toxicity from the recreational use of 1-benzylpiperazine. Clinical Toxicology 2008, 46(9):802-807.
23. Gee P., Richardson S. Researching the toxicity of party pills. Nursing New Zealand 2005, 11:12-13.
24. Gee P., Richardson S., Woltersdorf W., Moore G. Toxic effects of BZP-based herbal party pills in humans: A prospective study in Christchurch, New Zealand. New Zealand Medical Journal 2005, 118(1227). http://www.nzma.org.nz/journal/118-1227/1784.
25. Johnstone A.C., Lea R.A., Brennan K.A., Schenk S., Kennedy M.A., Fitzmaurice P.S. Benzylpiperazine: A drug of abuse?. Journal of Psychopharmacology 2007, 21(8):888-894.
26. Kenyon S., Button J., Ramsey J., Holt D.W. 'Legal highs'-Analysis of tablets and capsules containing piperazines 2007, University of London, London.
27. King L.A., Van-Der Meer A.J.P. New synthetic drugs in the European Union. Science & Justice 2001, 41(3):200-202.
28. Nicholson T.C. Prevalence of use, epidemiology and toxicity of 'herbal party pills' among those presenting to the emergency department. Emergency Medicine Australasia 2006, 18:180-184.
29. Nikolova I., Danchev N. Piperazine based substances of abuse: A new party pills on Bulgarian drug market. Biotechnology & Biotechnological Equipment 2008, 22(2):652-655.
30. Nutt, D. (2010). Mephedrone: The class D solution. The Guardian. 17 March. Retrieved 18th October 2010 from http://www.guardian.co.uk/commentisfree/2010/mar/17/mephedrone-class-d-solution-criminalise.
31. Russell B. Party pills-How little is known?. New Zealand Family Practitioner 2006, 33(1):46-48.
32. Sheridan J., Butler R. Legal party pills and their use by young people in New Zealand: A qualitative study. Final report of findings 2007, University of Auckland, Auckland, (revised June 2007).
33. Sheridan J., Butler R. " They're legal so they're safe, right?" What did the legal status of BZP-party pills mean to young people in New Zealand?. International Journal of Drug Policy 2010, 21(1):77-81.
34. Social Tonics Association of New Zealand. (2005). Submission of Social Tonics Association of New Zealand to the Health Select Committee on the matter of Misuse of Drugs Amendment Bill (No. 3) and the Supplementary Order Paper. Auckland: Social Tonics Association of New Zealand.
35. Theron L., Jansen K., Miles J. Benzylpiperazine-based party pills' impact on the Auckland City Hospital Emergency Department Overdose Database (2002-2004) compared with ecstasy (MDMA or methylene dioxymethamphetamine), gamma hydroxybutyrate (GHB), amphetamines, cocaine, and alcohol. New Zealand Medical Journal 2007, 120(1249). http://www.nzma.org.nz/journal/120-1249/2416.
36. Thompson I., Williams G., Aldington S., Williams M., Caldwell B., Dickson S., et al. The benzylpiperazine (BZP)/trifluoromethylphenylpiperazine (TFMPP) and alcohol safety study 2006, Medical Research Institute of New Zealand, Wellington.
37. Vince G. Mind altering drugs: Does legal mean safe?. New Scientist 2006, 191(2571):40-45.
38. Wikstrom M., Holmgren P., Ahlner J. A2 (N-benzylpiperazine) a new drug of abuse in Sweden. Journal of Analytical Toxicology 2004, 28(1):67-70.
39. Wilkins C., Girling M., Sweetsur P. The prevalence of use, dependency and harms of legal 'party pills' containing benzylpiperazine (BZP) and trifluorophenylmethylpiperazine (TFMPP) in New Zealand. Journal of Substance Use 2007, 12(3):213-224.
40. Wilkins C., Girling M., Sweetsur P., Huckle T., Huakau J. Legal party pill use in New Zealand: Prevalence of use, availability, health harms and 'gateway effects' of benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) 2006, Centre for Social and Health Outcomes Research and Evaluation (SHORE), Massey University, Auckland.
41. Wilkins C., Griffiths R., Sweetsur P. Recent trends in illegal drug use in New Zealand, 2006-2009. Findings from the 2006, 2007, 2008 and 2009 Illicit Drug Monitoring System (IDMS) 2010, Centre for Social and Health Outcomes Research and Evaluation (SHORE), Massey University, Auckland.
42. Wilkins C., Sweetsur P. Differences in harm from legal BZP/TFMPP party pills between North Island and South Island users in New Zealand: A case of effective industry self-regulation?. International Journal of Drug Policy 2010, 21(1):86-90.
43. Wilkins C., Sweetsur P., Casswell S. Recent population trends in amphetamine use in New Zealand: Comparisons of findings from national household drug surveying in 1998, 2001, and 2003. New Zealand Medical Journal 2006, 119(1244). http://www.nzma.org.nz/journal/119-1244/2285.
44. Winstock A.R., Ramsey J.D. Legal highs and the challenges for policy makers. Addiction 2010, 105:1685-1687.